Document Detail


Amplification of the RARA gene in acute myeloid leukemia: significant finding or coincidental observation?
MedLine Citation:
PMID:  20804918     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Oncogene amplification resulting in aberrant expression, although common in solid tumors, is rare in acute myeloid leukemia (AML) and is mostly associated with amplification of MYC, RUNX1, and MLL genes. Retinoic acid receptor alpha (RARA) and other target sequences at 17p11.2 often represent the amplicons expressed in breast cancer, not in AML. We present a unique case of a 59-year-old female with a history of breast cancer, now presenting with pancytopenia and bilateral infiltration with effusion in nodules of the right upper lobe of the lung. She was diagnosed with AML-M5. Chromosome analysis demonstrated a hypodiploid clone with complex numerical/structural abnormalities including 5q deletion, monosomy 7, as well as structurally rearranged chromosome 11 and several marker chromosomes. Fluorescence in situ hybridization (FISH) analysis showed amplification of RARA, loss of 7q, monosomy 7, loss of DEK (6p23), and additional copies of NUP214 (9q34) and MLL (11q23). Additional FISH studies showed both ERBB2 and TOP2A genes, which were co-amplified on one of the marker chromosomes. The follow-up bone marrow did not yield any metaphases, but FISH was normal for all probes, including RARA. After a short remission, the patient relapsed and showed clonal evolution. Additional case reports are necessary to assess whether RARA amplification in hematologic malignancies serves as an independent prognostic factor.
Authors:
Anna D Asleson; Vickie Morgan; Stephen Smith; Gopalrao V N Velagaleti
Related Documents :
20224268 - Isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia resulting in an addi...
18663748 - Nfib rearrangement in superficial, retroperitoneal, and colonic lipomas with aberration...
18067018 - Specific pattern of protein expression in acute myeloid leukemia harboring flt3-itd mut...
11886378 - A highly specific and sensitive fluorescence in situ hybridization assay for the detect...
8551508 - Parasitism of aedes aegypti and ae. albopictus (diptera: culicidae) by ascogregarina sp...
18163988 - The actin-related protein harp8 accumulates on the mitotic chromosomes and functions in...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cancer genetics and cytogenetics     Volume:  202     ISSN:  1873-4456     ISO Abbreviation:  Cancer Genet. Cytogenet.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-08-31     Completed Date:  2010-09-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7909240     Medline TA:  Cancer Genet Cytogenet     Country:  United States    
Other Details:
Languages:  eng     Pagination:  33-7     Citation Subset:  IM    
Copyright Information:
2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55906, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chromosome Mapping
Chromosomes, Human, Pair 11 / genetics
Female
Flow Cytometry
Gene Amplification*
Humans
In Situ Hybridization, Fluorescence
Karyotyping
Leukemia, Myeloid, Acute / genetics*,  pathology
Middle Aged
Receptors, Retinoic Acid / genetics*
Chemical
Reg. No./Substance:
0/Receptors, Retinoic Acid; 0/retinoic acid receptor alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Novel BRCA1/2 mutations in Serbian breast and breast-ovarian cancer patients with hereditary predisp...
Next Document:  A case of angioimmunoblastic T-cell non-Hodgkin lymphoma with a neocentric inv dup(1).